Atlas Trials

A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)

Clinical trial NCT03505892 · COMPLETED

Trial details

NCT number
NCT03505892
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Ankylosing Spondylitis (AS)
Start date
2018-06-05
Primary completion
2021-10-25
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.